The aim of this study was to characterize hepatitis C virus (HCV) epidemiology in Iran and
estimate the pooled mean HCV antibody prevalence in different risk populations. We …

Aim Methamphetamine use is a new health concern in Iran, the most populated Persian Gulf
country. However, there is no well-documented literature. The current study objectives were …

Backgrounds and aims Iran has 2.1 and 1.8% of its 15–64‐year‐old population living with
illicit substance and opioid use disorders, respectively. To address these problems, Iran has …

Because of the proximity of Persian Iran to Afghanistan, the main opium producer in the
world, drug use especially opium use has a long history in Iran. Opium and its residues are …

Background Relapse is one of the main challenges that must be tackled in the drug
addiction treatment. Different factors contribute to the relapse process but it remains unclear …

Objective To determine the prevalence of HIV infection among homeless men and women
and the related risk behaviors in Tehran, Iran. Methods In 2007–2008, Tehran municipality …

Drug-including opioid-dependence is common in correctional populations, however little
research exists on interventions for women offenders. Based on retrospective administrative …

Abstract HIV/AIDS and hepatitis C among people who inject drugs are on the rise in the
Middle East and North Africa (MENA) region. But the regional response to the epidemic falls …

Background Methadone maintenance therapy (MMT) is provided to patients with opioid use
disorder (OUD). However, as with all opioids, methadone impacts negatively on sexual …

Abstract Background Iran (Persia) has a women-only drug treatment system. However,
literature is not documented. The current study aimed to review the development of women …